ME
MET.US MetLife Inc
- Market cap
- USD 64.5B
- P/E
- 13.4x
- P/B
- 2.90x
- ROE
- 25.9%
- Dividend yield
- 2.64%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is MET.US undervalued?
Graham numberMET.US trades 31.6% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
MetLife Inc fundamental analysis
No fundamental analysis for MetLife Inc yet.
MetLife Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About MetLife Inc
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates in six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment, accident and health, visi…
Full company profileMetLife Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
MetLife Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 60.5B | 62.3B | 67.9B | 69.6B | 67.9B | 63.4B | 68.0B | 67.7B | 71.0B | 77.1B | 78.0B |
| Gross Profit | 14.0B | 13.5B | 15.9B | 16.2B | 15.5B | 16.8B | 18.9B | 17.3B | 20.0B | 28.0B | 22.4B |
| Operating Income | 4.28B | 3.54B | 6.31B | 6.80B | 6.93B | 8.52B | 6.36B | 2.16B | 6.66B | 4.66B | 7.78B |
| EBITDA | 6.09B | 5.46B | 8.06B | 8.38B | 8.46B | 10.1B | 7.98B | 3.93B | 7.37B | 6.48B | 8.52B |
| Net Income | 850M | 4.01B | 5.12B | 5.90B | 5.41B | 6.86B | 5.28B | 1.58B | 4.43B | 3.38B | 5.76B |
| EPS | 0.78 | 3.84 | 5.05 | 6.25 | 5.92 | 7.88 | 6.53 | 2.07 | 6.22 | 5.08 | 9.00 |
| Balance Sheet | |||||||||||
| Total Assets | 899B | 720B | 688B | 740B | 795B | 760B | 663B | 688B | 677B | 745B | 745B |
| Total Liabilities | 831B | 661B | 635B | 674B | 720B | 692B | 633B | 657B | 650B | 716B | 722B |
| Shareholders' Equity | 67.5B | 58.7B | 52.7B | 66.1B | 74.6B | 67.5B | 29.9B | 30.0B | 27.4B | 28.4B | 22.2B |
| Cash & Short-term Investments | 312B | 327B | 318B | 348B | 379B | 367B | 313B | 317B | 109B | 125B | 354B |
| Total Debt | 19.9B | 19.3B | 16.2B | 16.9B | 18.1B | 17.4B | 18.0B | 18.8B | 18.7B | 20.2B | 21.7B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 14.7B | 12.7B | 9.53B | 13.8B | 11.6B | 12.6B | 13.2B | 14.3B | 15.1B | 18.1B | 9.22B |
| Capital Expenditure | 8.53B | 4.56B | 7.07B | 5.65B | 4.27B | 4.36B | 0.00 | 1.17B | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | 6.13B | 8.16B | 2.46B | 8.13B | 7.37B | 8.24B | 13.2B | 13.1B | 15.1B | 18.1B | 9.22B |
| Ratios | |||||||||||
| ROE | 1.3% | 6.8% | 9.7% | 8.9% | 7.3% | 10.2% | 17.7% | 5.3% | 16.1% | 11.9% | 25.9% |
| ROA | 0.1% | 0.6% | 0.7% | 0.8% | 0.7% | 0.9% | 0.8% | 0.2% | 0.7% | 0.5% | 0.8% |
| Net Profit Margin | 1.4% | 6.4% | 7.5% | 8.5% | 8.0% | 10.8% | 7.8% | 2.3% | 6.2% | 4.4% | 7.4% |
| Debt to Equity | 0.29x | 0.33x | 0.31x | 0.25x | 0.24x | 0.26x | 0.60x | 0.63x | 0.68x | 0.71x | 0.98x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
MetLife Inc dividends
- Dividend yield
- 2.64%
- Forward dividend
- 2.37 USD
- Payout ratio
- 50.4%
- Ex-dividend date
- Nov 3, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | USD 1.70B | 2.56 | 50.4% |
| 2024 | USD 1.73B | 2.43 | 39.0% |
| 2023 | USD 1.76B | 2.31 | 111.8% |
| 2022 | USD 1.78B | 2.20 | 33.7% |
| 2021 | USD 1.84B | 2.12 | 26.9% |
| 2020 | USD 1.86B | 2.04 | 34.4% |
| 2019 | USD 1.82B | 1.93 | 30.9% |
| 2018 | USD 1.82B | 1.79 | 35.5% |
| 2017 | USD 1.82B | 1.74 | 45.4% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1122:1000 on Aug 7, 2017.
Who owns MetLife Inc
- Insiders 16.56%
- Institutions 78.17%
- Public & others 5.28%
- Shares outstanding 628M
- Free float 526M
Top funds holding MET.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Dodge & Cox Stock I | 23.3M | 3.71% | -32.63% | Sep 2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 17.1M | 2.73% | -1.34% | Sep 2026 |
| Vanguard 500 Index Investor | 14.0M | 2.23% | -2.36% | Sep 2026 |
| Vanguard MStar Mid Cap Index Instl | 11.6M | 1.84% | -2.23% | Sep 2026 |
| iShares Core S&P 500 ETF | 7.12M | 1.13% | +0.17% | Oct 2026 |
| Fidelity 500 Index | 6.94M | 1.10% | -1.12% | Sep 2026 |
| State Street® SPDR® S&P 500® ETF | 6.49M | 1.03% | -0.25% | Oct 2026 |
| Vanguard MStar Value Index Investor | 5.15M | 0.82% | -1.52% | Sep 2026 |
| T. Rowe Price Equity Income | 4.18M | 0.66% | 0.00% | Sep 2026 |
| Vanguard Windsor Investor Shares | 4.10M | 0.65% | -2.35% | Sep 2026 |
| State Street®FinSelSectSPDR®ETF | 3.59M | 0.57% | +1.67% | Oct 2026 |
| Vanguard MStar Mid Cap Value ETF | 3.37M | 0.54% | -4.75% | Sep 2026 |
| iShares Select Dividend ETF | 3.10M | 0.49% | +0.83% | Oct 2026 |
| Vanguard Dividend Appreciation ETF | 3.02M | 0.48% | -1.29% | Sep 2026 |
| Vanguard Institutional Index I | 2.82M | 0.45% | -2.23% | Sep 2026 |
| Bridge Builder Large Cap Value | 2.49M | 0.40% | -7.68% | Oct 2026 |
| Vanguard High Dividend Yield ETF | 2.20M | 0.35% | +0.28% | Sep 2026 |
| ClearBridge Dividend Strategy A | 2.12M | 0.34% | 0.00% | Sep 2026 |
| Invesco S&P 500® Equal Weight ETF | 2.06M | 0.33% | +0.17% | Oct 2026 |
| T. Rowe Price Value | 1.73M | 0.28% | 0.00% | Sep 2026 |
Top institutions holding MET.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| BlackRock Inc | 51.8M | 8.24% | +0.71% | Jun 2026 |
| Dodge & Cox | 48.4M | 7.71% | -5.25% | Jun 2026 |
| Vanguard Capital Management, LLC | 35.5M | 5.65% | -1.04% | Jun 2026 |
| Vanguard Portfolio Management, LLC | 30.0M | 4.78% | -2.54% | Jun 2026 |
| State Street Corp | 25.3M | 4.03% | +0.46% | Jun 2026 |
| T. Rowe Price Associates, Inc. | 21.3M | 3.39% | -6.59% | Jun 2026 |
| Geode Capital Management, LLC | 13.3M | 2.12% | +0.50% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 12.5M | 1.99% | +12.69% | Jun 2026 |
| Pzena Investment Management, LLC | 11.1M | 1.77% | -1.53% | Jun 2026 |
| Dimensional Fund Advisors, Inc. | 7.59M | 1.21% | +5.53% | Sep 2026 |
| Amvescap Plc. | 6.93M | 1.10% | +0.15% | Jun 2026 |
| NORGES BANK | 6.82M | 1.09% | -15.88% | Jun 2026 |
| The Goldman Sachs Group Inc | 6.63M | 1.05% | +6.73% | Jun 2026 |
| Northern Trust Corp | 6.30M | 1.00% | -0.55% | Jun 2026 |
| UBS Asset Mgmt Americas Inc | 6.03M | 0.96% | +5.92% | Jun 2026 |
| Nordea Investment Mgmt Bank Demark A/s | 5.99M | 0.95% | +18.84% | Sep 2026 |
| Arrowstreet Capital Limited Partnership | 5.81M | 0.92% | +87.46% | Jun 2026 |
| ClearBridge Advisors, LLC | 5.64M | 0.90% | +9.54% | Jun 2026 |
| Bank of America Corp | 5.38M | 0.86% | -2.13% | Jun 2026 |
| AQR Capital Management LLC | 4.12M | 0.66% | +13.08% | Jun 2026 |
MetLife Inc company profile
- Company name
- MetLife Inc
- Ticker
- MET.US
- Exchange
- USA Stocks
- Listed since
- Apr 5, 2000
- Sector
- Financial Services
- Industry
- Insurance
- Employees
- 46,000
- Fiscal year end
- December
- Address
- 200 Park Avenue, New York, NY, United States, 10166-0188
- Phone
- 212 578 9500
- Website
- metlife.com
About MetLife Inc
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates in six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment, accident and health, vision, and pet insurance, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it offers fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity and funded reinsurance solutions; credit insurance products; accident & health products covering hospitalization, cancer, critical illness, income protection, and scheduled medical reimbursement plans; and protection against long-term health care services. The company was incorporated in 1999 and is based in New York, New York.
MetLife Inc management
10- Mr. Michel Abbas KhalafCEO, President & Director
- Mr. John Dennis McCallion CPAExecutive VP, CFO & Head of Investment Management · born 1974
- Mr. Bill PappasExecutive VP and Head of Global Technology & Operations · born 1970
- Ms. Marlene Beverly DebelExecutive VP, Chief Risk Officer & Head of Insurance Investments · born 1967
- Mr. Ramy TadrosRegional President of U.S. Business & Head of MetLife Holdings · born 1976
- Ms. Adrienne Karen O'Neill C.A., C.F.A., CPAExecutive VP & Chief Accounting Officer
- Mr. John Arthur HallSenior VP, Head of Investor Relations & Executive VP and Treasurer
- Ms. Monica M. CurtisExecutive VP, Chief Legal Officer & Head of Government Relations · born 1983
- Ms. Jane SlusarkChief Communications Officer
- Mr. Michael RobertsExecutive VP & Chief Marketing Officer